YAP activates pancreatic stellate cells and enhances pancreatic fibrosis.

[1]  B. Pogue,et al.  EUS-guided verteporfin photodynamic therapy for pancreatic cancer. , 2021, Gastrointestinal endoscopy.

[2]  Hui Guo,et al.  Downregulation of TRIM27 suppresses gastric cancer cell proliferation via inhibition of the Hippo-BIRC5 pathway. , 2020, Pathology, research and practice.

[3]  S. Dupont,et al.  YAP/TAZ functions and their regulation at a glance , 2020, Journal of Cell Science.

[4]  Bicheng Chen,et al.  Molecular Mechanism of Pancreatic Stellate Cells Activation in Chronic Pancreatitis and Pancreatic Cancer , 2020, Journal of Cancer.

[5]  Vikesh K. Singh,et al.  Diagnosis and Management of Chronic Pancreatitis: A Review. , 2019, JAMA.

[6]  R. Waldron,et al.  Yes-Associated Protein 1 Plays Major Roles in Pancreatic Stellate Cell Activation and Fibroinflammatory Responses , 2019, Front. Physiol..

[7]  H. Nizze,et al.  Different characteristics of chronic dibutyltin dichloride-induced pancreatitis and cholangitis in mouse and rat. , 2019, Hepatobiliary & pancreatic diseases international : HBPD INT.

[8]  K. Guan,et al.  The Hippo Pathway: Biology and Pathophysiology. , 2019, Annual review of biochemistry.

[9]  M. Sherman.  Stellate Cells in Tissue Repair, Inflammation, and Cancer. , 2018, Annual review of cell and developmental biology.

[10]  G. Eibl,et al.  Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival , 2018, Signal Transduction and Targeted Therapy.

[11]  B. Krause,et al.  Antifibrogenic effects of vitamin D derivatives on mouse pancreatic stellate cells , 2018, World journal of gastroenterology.

[12]  Jing Pan,et al.  CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma , 2017, International journal of molecular medicine.

[13]  Xuexiang Han,et al.  A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer. , 2017, Cancer letters.

[14]  J. Li,et al.  Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP‐TEAD complex , 2017, Cancer science.

[15]  M. Greene,et al.  Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis , 2015, Scientific Reports.

[16]  T. Hasan,et al.  Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer , 2014, British Journal of Cancer.

[17]  K. Hirata,et al.  Treatment of pancreatic fibrosis with siRNA against a collagen-specific chaperone in vitamin A-coupled liposomes , 2012, Gut.

[18]  B. Pützer,et al.  Senescence determines the fate of activated rat pancreatic stellate cells , 2012, Journal of cellular and molecular medicine.

[19]  Jun O. Liu,et al.  Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. , 2012, Genes & development.

[20]  H. Friess,et al.  StellaTUM: current consensus and discussion on pancreatic stellate cell research , 2011, Gut.

[21]  Xiaolong Yang,et al.  Taxol resistance in breast cancer cells is mediated by the hippo pathway component TAZ and its downstream transcriptional targets Cyr61 and CTGF. , 2011, Cancer research.

[22]  S. Lowe,et al.  AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma , 2011, Oncogene.

[23]  R. Jaster,et al.  Bone marrow-derived pancreatic stellate cells in rats , 2010, Cell Research.

[24]  Olaf Wolkenhauer,et al.  Mathematical modelling of interferon-gamma signalling in pancreatic stellate cells reflects and predicts the dynamics of STAT1 pathway activity. , 2010, Cellular signalling.

[25]  R. Jaster,et al.  Molecular insights into connective tissue growth factor action in rat pancreatic stellate cells. , 2008, Cellular signalling.

[26]  R. Jaster,et al.  Inhibitory effects of interferons on pancreatic stellate cell activation. , 2006, World journal of gastroenterology.

[27]  L. Gierl,et al.  Peroxisome proliferator ‐ activated receptor γ overexpression inhibits pro‐fibrogenic activities of immortalised rat pancreatic stellate cells , 2005 .

[28]  H. Thiesen,et al.  Generation and characterization of immortalized rat pancreatic stellate cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[29]  A. Masamune,et al.  Inhibition of p38 Mitogen-Activated Protein Kinase Blocks Activation of Rat Pancreatic Stellate Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[30]  R. Jaster,et al.  Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells , 2002, Gut.

[31]  R. Schmid,et al.  Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. , 2001, American journal of physiology. Cell physiology.

[32]  G. Adler,et al.  Platelet-Derived Growth Factors Stimulate Proliferation and Extracellular Matrix Synthesis of Pancreatic Stellate Cells: Implications in Pathogenesis of Pancreas Fibrosis , 2000, Laboratory Investigation.

[33]  R. Schmid,et al.  Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.

[34]  M. Korsten,et al.  Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture , 1998, Gut.

[35]  M. Löhr,et al.  Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. , 1997, Gastroenterology.